About 260 results

ALLMedicine™ Amyopathic Dermatomyositis Center

Research & Reviews  95 results

Clinical features and immune-related protein patterns of anti-MDA5 positive clinically ...
Rheumatology (Oxford, England); Hensgens MPM, Delemarre EM et. al.

Jan 21st, 2022 - The presence of melanoma differentiation-associated protein 5 (MDA5) antibodies in patients with dermatomyositis (DM) is associated with the development of a rapidly progressive interstitial lung disease (RPILD), unresponsive to conventional treat...

Idiopathic inflammatory myopathies.
https://doi.org/10.1038/s41572-021-00321-x 10.1101/494062 10.1093/rheumatology/keab492
Nature Reviews. Disease Primers; Lundberg IE, Fujimoto M et. al.

Dec 4th, 2021 - Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous group of autoimmune disorders with varying clinical manifestations, treatment responses and prognoses. Muscle weakness is usually the classical clinical manifest...

Extensive myofascia calcinosis in an adult patient with amyopathic dermatomyositis.
Rheumatology (Oxford, England); Yang XS, Zhu L et. al.

Nov 4th, 2021 - Extensive myofascia calcinosis in an adult patient with amyopathic dermatomyositis.|2021|Yang XS,Zhu L,Lv ZF,|

Anti-MDA5 Antibody-Associated Clinically Amyopathic Dermatomyositis: Case Report and Li...
Journal of General Internal Medicine; Kersey CB, Oshinsky C et. al.

Sep 26th, 2021 - Anti-MDA5 Antibody-Associated Clinically Amyopathic Dermatomyositis: Case Report and Literature Review.|2021|Kersey CB,Oshinsky C,Wahl ER,Newman TA,|

Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-tra...
Rheumatology (Oxford, England); Zhao Q, Chen Y et. al.

Sep 12th, 2021 - Dermatomyositis (DM) and clinically amyopathic dermatomyositis (CADM) patients with positive expression of anti-transcription intermediary factor 1-γ (anti-TIF1-γ) antibody (Ab) are characterized by distinct clinicopathological features. We aimed ...

see more →

Clinicaltrials.gov  1 results

Basiliximab Treating Interstitial Pneumonia of CADM

Jun 20th, 2017 - This is a 52-week, randomized, open and routine treatment controlled study. This study will assess the safety and efficacy of basiliximab as an add-on treatment for interstitial pneumonia in clinical amyopathic dermatomyositis (CADM) patients. 100...

see more →

News  8 results

Papules and Telangiectases on the Distal Fingers of a Child
Briana Brown, DO, Jacqueline Jones, DO et. al.

Apr 8th, 2019 - The Diagnosis: Juvenile Dermatomyositis Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory myopathy of childhood that is autoimmune in nature with an annual incidence ranging from 2. 5 to 4.

Timely dermatomyositis diagnosis, treatment remain elusive

Jun 3rd, 2018 - “We saw that there was a much higher rate of misdiagnosis in patients who didn’t have any muscle disease. We have to raise awareness that amyopathic dermatomyositis is a very prevalent condition,” Dr.

Antibody Predicts Lung Disease in Myositis

Oct 1st, 2015 - Action Points Interstitiallung disease (ILD) is an under-recognized and deadly complication of dermatomyositis (DM), a rare autoimmune disease. The anti-MDA5 autoantibody is significantly associated with ILD, rapidly progressive ILD and worse pulm...

Cyclophosphamide May Ease Idiopathic Inflammatory Myopathies

Nov 19th, 2014 - Cyclophosphamide (CYC) improves muscle strength and function as well as pulmonary function in patients with idiopathic inflammatory myopathies (IIMs) and/or IIM-related interstitial lung disease (IIM-ILD), a new systematic review found. The review...

see more →